My Theory On Redmile Investment31 Oct 2020 08:57
Here is my hypothesis on the Redmile investments.
When Redmile made their first investment I believe they already fully understood the potential of Scancell’s products. They are a top class biotech investor and I don’t think they invested in a tiny UK biotech without first doing their research.
I also believe that they had 2 clear objectives from the beginning:-
1. Take a big stake in Scancell in order to get a large return.
2. In doing so, provide Scancell with sufficient financial firepower to progress their products rapidly so that this return comes as quickly as possible.
So, if this was their objective what did they not simply invest £40m back in August ?
I think the answer to this is that to raise £40m at 5.5p Scancell would have had to issue 727m shares. Given that there were only 465m shares in issue at the time this would have meant that Redmile would be getting 60% of the company for £40m. Not withstanding the take-over implications, I’m sure that all major shareholders and many PI’s would have voted against such a cheap give-away of most of Scancell.
So, I believe that Redmile are making their investment in a series of tranches where they build up an increasing stake at prices that are acceptable to the shareholders (i.e. will be approved at the related GM’s). They will of course always try go get the largest stake they can get voted through at the lowest cost - maybe the parties voting against think the current fundraise amount of £30m priced at 13p gives Redmile too big a stake for too little cost ?
It may be that this investment will be Redmile’s last tranche, or they may be back for more in the future at a higher price - I suspect the former because if the motion is approved at the GM Scancell will have enough cash to get solid data on several products and, if the data is good, will be able to strike deals or will get bought out for (IMO) significantly more than 1 billion.
I voted for the motion btw.